000 01454 a2200409 4500
005 20250518061237.0
264 0 _c20200728
008 202007s 0 0 eng d
022 _a1872-8332
024 7 _a10.1016/j.lungcan.2019.08.002
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCheng, Hua
245 0 0 _aA meta-analysis of adjuvant EGFR-TKIs for patients with resected non-small cell lung cancer.
_h[electronic resource]
260 _bLung cancer (Amsterdam, Netherlands)
_c11 2019
300 _a7-13 p.
_bdigital
500 _aPublication Type: Journal Article; Meta-Analysis
650 0 4 _aBiomarkers, Tumor
_xgenetics
650 0 4 _aCarcinoma, Non-Small-Cell Lung
_xdrug therapy
650 0 4 _aChemotherapy, Adjuvant
650 0 4 _aErbB Receptors
_xantagonists & inhibitors
650 0 4 _aHumans
650 0 4 _aLung Neoplasms
_xdrug therapy
650 0 4 _aMolecular Targeted Therapy
650 0 4 _aMutation
650 0 4 _aPrognosis
650 0 4 _aProtein Kinase Inhibitors
_xtherapeutic use
650 0 4 _aRandomized Controlled Trials as Topic
700 1 _aLi, Xiao-Jian
700 1 _aWang, Xiao-Jin
700 1 _aChen, Zuo-Wen
700 1 _aWang, Rui-Qi
700 1 _aZhong, Hong-Cheng
700 1 _aWu, Tian-Chi
700 1 _aCao, Qing-Dong
773 0 _tLung cancer (Amsterdam, Netherlands)
_gvol. 137
_gp. 7-13
856 4 0 _uhttps://doi.org/10.1016/j.lungcan.2019.08.002
_zAvailable from publisher's website
999 _c30111881
_d30111881